Lunai Bioworks Inc. LNAI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 52.00K | 20.90K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.00K | 20.90K | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 52.00K | 20.90K | -- | -- | -- |
| SG&A Expenses | 7.80M | 9.60M | 12.40M | 14.99M | 17.88M |
| Depreciation & Amortization | 93.50K | 102.20K | 123.20K | 144.00K | 134.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.92M | 9.87M | 12.58M | 15.30M | 18.55M |
| Operating Income | -7.87M | -9.85M | -12.58M | -15.30M | -18.55M |
| Income Before Tax | -3.56M | -128.28M | -125.52M | -130.98M | -178.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.56 | -128.28 | -125.52 | -130.98 | -178.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.56M | -128.28M | -125.52M | -130.98M | -178.01M |
| EBIT | -7.87M | -9.85M | -12.58M | -15.30M | -18.55M |
| EBITDA | -7.78M | -9.75M | -12.46M | -15.17M | -18.42M |
| EPS Basic | -0.88 | -58.00 | -57.09 | -60.06 | -83.17 |
| Normalized Basic EPS | -1.57 | -2.51 | -3.54 | -4.57 | -5.83 |
| EPS Diluted | -0.88 | -58.00 | -57.09 | -60.06 | -83.17 |
| Normalized Diluted EPS | -1.57 | -2.51 | -3.53 | -4.56 | -5.81 |
| Average Basic Shares Outstanding | 13.41M | 11.08M | 9.98M | 9.07M | 8.25M |
| Average Diluted Shares Outstanding | 13.41M | 11.08M | 10.00M | 9.09M | 8.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |